Terms: = Lymphoma AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL AND Treatment
7 results:
1. Timing of Central Venous Line Insertion During Induction in Children With Acute Lymphoblastic Leukemia.
Ataseven E; Yilmaz Ş; Tüfekçi Ö; Ören H
J Pediatr Hematol Oncol; 2023 Jan; 45(1):25-28. PubMed ID: 36598960
[TBL] [Abstract] [Full Text] [Related]
2. Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell lymphoma.
Zhao J; Su L; Zhong J
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e858-e863. PubMed ID: 32680777
[TBL] [Abstract] [Full Text] [Related]
3. Different Types of
He Y; Sheng W; Hu W; Lin J; Liu J; Yu B; Mao X; Zhang L; Huang J; Wang G
Oncol Res; 2019 Aug; 27(8):901-910. PubMed ID: 30940295
[No Abstract] [Full Text] [Related]
4. Thrombosis in pediatric patients with leukemia.
Levy-Mendelovich S; Barg AA; Kenet G
Thromb Res; 2018 Apr; 164 Suppl 1():S94-S97. PubMed ID: 29703491
[TBL] [Abstract] [Full Text] [Related]
5. A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.
Roininen S; Laine O; Kauppila M; Vesanen M; Rämet M; Sinisalo M; Jantunen E; Säily M; Räty R; Elonen E; Wartiovaara-Kautto U
Cancer Med; 2017 Jun; 6(6):1275-1285. PubMed ID: 28503810
[TBL] [Abstract] [Full Text] [Related]
6. Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers.
Facchinetti F; Loriot Y; Kuo MS; Mahjoubi L; Lacroix L; Planchard D; Besse B; Farace F; Auger N; Remon J; Scoazec JY; André F; Soria JC; Friboulet L
Clin Cancer Res; 2016 Dec; 22(24):5983-5991. PubMed ID: 27401242
[TBL] [Abstract] [Full Text] [Related]
7. Late vascular occlusion of central lines in pediatric malignancies.
Wilimas JA; Hudson M; Rao B; Luo X; Lott L; Kaste SC
Pediatrics; 1998 Feb; 101(2):E7. PubMed ID: 9445517
[TBL] [Abstract] [Full Text] [Related]
